2 - TI Pharma
2 - TI Pharma 2 - TI Pharma
Chapter 9 Glycosphingolipid Metabolism and Mitochondrial Function do not Explain Glucocorticoid-Induced Insulin Resistance in Healthy Men D.H. van Raalte*, M. Brands*, M. João Ferraz, H.P. Sauerwein, A.J.Verhoeven, J.F.G.Aerts, M.Diamant and M.J. Serlie *Both authors contributed equally Submitted
- Page 302: Chapter 8 Low-dose Glucocorticoid T
- Page 306: Glucocorticoids (GCs) are the corne
- Page 310: Experimental protocol - clamp: Afte
- Page 314: Statistics: Data are presented as m
- Page 318: Lipid Metabolism: Lipolysis in the
- Page 322: Figure 3. The effect of prednisolon
- Page 326: By including an additional treatmen
- Page 330: treating patients with GC therapy.
- Page 334: 16. Hoes jN, jacobs jW, Verstappen
- Page 338: 44. Schakman O, Gilson H, Thissen j
- Page 342: Supplementary Figure 3. Kinetic equ
- Page 346: Supplementary Table 2. Metabolic pa
- Page 354: INTRoDUCTIoN Glucocorticoids (GCs)
- Page 358: Experimental protocol: The design o
- Page 362: oxidative phosphorylation (OXPHOS)
- Page 366: Table 3. Mitochondrial respiration
Chapter 9<br />
Glycosphingolipid Metabolism and<br />
Mitochondrial Function do not Explain<br />
Glucocorticoid-Induced Insulin Resistance<br />
in Healthy Men<br />
D.H. van Raalte*, M. Brands*, M. João Ferraz, H.P. Sauerwein,<br />
A.J.Verhoeven, J.F.G.Aerts, M.Diamant and M.J. Serlie<br />
*Both authors contributed equally<br />
Submitted
Change language